DiscoverDeep Tech CatalystFrom Molecule to Market: What VCs Look for in Early-Stage Biotech Startups. A chat with Ingrid Kelly, Partner @ xista science ventures
From Molecule to Market: What VCs Look for in Early-Stage Biotech Startups. A chat with Ingrid Kelly, Partner @ xista science ventures

From Molecule to Market: What VCs Look for in Early-Stage Biotech Startups. A chat with Ingrid Kelly, Partner @ xista science ventures

Update: 2025-06-20
Share

Description

Host: Nicola Marchese

Guest: Ingrid Kelly, Partner @ xista science ventures

#DeepTechCatalyst


Watch the ⁠⁠⁠full conversation on our ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠platform⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠!⁠


Disclaimer: This content is provided solely for educational and informational purposes and should not be interpreted as financial or legal advice. Given the complexity and potential impact of these terms, it is crucial to consult with an attorney. Legal expertise is invaluable in navigating these technical aspects and ensuring that the terms are in your best interests before finalizing any agreements.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

From Molecule to Market: What VCs Look for in Early-Stage Biotech Startups. A chat with Ingrid Kelly, Partner @ xista science ventures

From Molecule to Market: What VCs Look for in Early-Stage Biotech Startups. A chat with Ingrid Kelly, Partner @ xista science ventures

The Scenarionist